We propose to continue our program to provide research training in oncology to young surgeons interested in a career in academic surgical oncology. Trainees will be surgical residents with at least 2 years of postgraduate clinical experience. Our Surgical Oncology Research Training Program has supported the research careers of approximately 50 young trainee surgeons over the past 25 years. We are now applying for funding of years 26-30. The goals of the two-year training program are to provide individuals with an intensive research experience in (1) hypothesis formulation, (2) experimental design, (3) data analysis, and (4) oral and written presentation. The ultimate objective of the program is to teach the scientific method and laboratory techniques so that the trainees can perform high quality independent research in oncology upon completion of their surgical training. This research experience will enable trainees to apply for positions as junior faculty members in academic institutions and become independent and mentored clinical investigators and translational researchers. The program will vary according to the interest of the trainees and their preceptors. The program curriculum is designed to provide exposure to basic and translational science, as well as medical oncology, radiation oncology and clinical surgical oncology. Past trainees have worked in a wide variety of disciplines, including tumor immunology, cancer cell biology, molecular genetics, molecular pathology, targeted therapeutics, and growth and differentiation. Close contact between the trainees, preceptors and program director has been achieved. Trainees are required to attend weekly conferences and didactic lectures at Memorial Sloan-Kettering Cancer Center (MSKCC) that include the fundamentals of research, research presentations as well as topics in clinical oncology. The scientific quality of research performed by the trainees has been outstanding, and most of the fellows in the past 10 years have remained in academia. The program continues to be a major commitment of the Department of Surgery and has benefited from the recent increase in research faculty and research facilities at our institution.
The Surgical Oncology Research Training Program has supported the research careers of approximately 50 young trainee surgeons over the past 25 years. The ultimate objective of the program is to teach the scientific method and laboratory techniques so that the trainees can perform high quality independent research in oncology upon completion of their surgical training.
|Zhang, Jennifer Q; Zeng, Shan; Vitiello, Gerardo A et al. (2018) Macrophages and CD8+ T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors. Cancer Immunol Res 6:434-447|
|Brandt, Whitney S; Bouabdallah, Ilies; Tan, Kay See et al. (2018) Factors associated with distant recurrence following R0 lobectomy for pN0 lung adenocarcinoma. J Thorac Cardiovasc Surg 155:1212-1224.e3|
|Brandt, Whitney S; Yan, Wanpu; Leeman, Jonathan E et al. (2018) Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung Cancer. Ann Thorac Surg 106:848-855|
|Vitiello, Gerardo A; Medina, Benjamin D; Zeng, Shan et al. (2018) Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor. Clin Cancer Res 24:972-984|
|Lee, Jun H; Chang, Kevin K; Yoon, Changhwan et al. (2018) Lauren Histologic Type Is the Most Important Factor Associated With Pattern of Recurrence Following Resection of Gastric Adenocarcinoma. Ann Surg 267:105-113|
|García Nores, Gabriela D; Ly, Catherine L; Savetsky, Ira L et al. (2018) Regulatory T Cells Mediate Local Immunosuppression in Lymphedema. J Invest Dermatol 138:325-335|
|Ly, Catherine L; Cuzzone, Daniel A; Kataru, Raghu P et al. (2018) Small numbers of CD4+ T cells can induce development of lymphedema. Plast Reconstr Surg :|
|García Nores, Gabriela D; Ly, Catherine L; Cuzzone, Daniel A et al. (2018) CD4+ T cells are activated in regional lymph nodes and migrate to skin to initiate lymphedema. Nat Commun 9:1970|
|Brandt, Whitney S; Yan, Wanpu; Zhou, Jian et al. (2018) Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis. J Thorac Cardiovasc Surg :|
|Gardenier, Jason C; Kataru, Raghu P; Hespe, Geoffrey E et al. (2017) Topical tacrolimus for the treatment of secondary lymphedema. Nat Commun 8:14345|
Showing the most recent 10 out of 166 publications